Log In
BCIQ
Print this Print this
 

KEA-0447, KRP-EPA605

  Manage Alerts
Collapse Summary General Information
Company Kyorin Pharmaceutical Co. Ltd.
DescriptionSelective prostaglandin E2 (PGE2) receptor EP1 subtype (Prostanoid EP1 receptor; PTGER1) antagonist
Molecular Target Prostaglandin E2 (PGE2) receptor EP1 subtype (Prostanoid EP1 receptor) (PTGER1)
Mechanism of ActionProstaglandin E2 (PGE2) receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationIncontinence
Indication DetailsTreat overactive bladder (OAB)
Regulatory Designation
PartnerKissei Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today